High Incidence of Appendix Carcinoid Tumors Among Candidates for Bariatric Surgery: Diagnostic and Therapeutic Implications
First Online: 26 February 2010 DOI:
Cite this article as: Crea, N., Pata, G., Di Betta, E. et al. OBES SURG (2011) 21: 151. doi:10.1007/s11695-010-0112-4 Abstract
Although the appendix has been recognized as a preferential site for carcinoid tumors in obese patients, no definitive guidelines are so far available regarding the management of these patients when candidates for bariatric surgery. This study was designed to fill that gap. Between 2000-2008, 558 patients underwent bariatric procedures. Appendectomy was routinely performed in 477 cases. Their charts were retrospectively retrieved and histopathology responses on surgical specimens were recorded. We aimed to assess: incidence of appendix carcinoid tumors (ACTs) and any possible risk-factor; modality of diagnosis (pre-, intra- or post-operatively); impact on the planned bariatric procedure; treatment reserved to such cases. Typical ACTs were diagnosed in 7 patients (1.4%) (median age: 33 years; median BMI: 49 kg/m²; males/females: 1/6). Four were diagnosed intra-operatively. Because of dimensions (<2 cm) and absence of mesoappendiceal or serosal involvement, simple appendectomy was performed during bariatric procedure, as planned. Three were diagnosed post-operatively (all <2 cm). In 1 case right hemicolectomy was performed 1 month later due to mesoappendiceal involvement. No appendectomy-related complication was encountered. All patients remained tumor-free during follow-up (mean: 64 months; range, 25-92). Young age, female sex, high BMI and diabetes mellitus resulted significantly associated with ACT. Our study sustains routine appendectomy or at least careful investigation of the appendix during bariatric surgery. For tumors <2 cm without mesoappendiceal or serosal involvement, simple appendectomy proved sufficient. Bariatric surgery did not have a negative effect on the treatment of malignancies that are discovered intra- or post-operatively.
Keywords Appendix Carcinoid tumors Obesity Surgery Management References
Pischon T, Boeing H, Hoffmann K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med. 2008;359:2105–20.
Mokdad AH, Marks JS, Stoup DF, et al. Actual causes of death in the United States, 2000. JAMA. 2004;291:1238–64.
Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240:416–23.
Ammar KA, Redfield MM, Mahoney DW, et al. Central obesity: association with left ventricular dysfunction and mortality in the community. Am Heart J. 2008;156:975–81.
Shimabukuro M. Cardiac adiposity and global cardiometabolic risk: new concept and clinical intervention. Circ J. 2008;73:27–34.
Artham SM, Lavie CJ, Patel HM. Impact of obesity on the risk of heart failure and its prognosis. J Cardiometab Syndr. 2008;3:155–61.
Crea N, Pata G, Della Casa D, et al. Improvement of metabolic syndrome following intragastric balloon: 1 year follow-up analysis. Obes Surg. 2009;19:1084–8.
McCawley AM, Ferriss JS, Geffel D, et al. Cancer in obese women: potential protective impact of bariatric surgery. J Am Coll Surg. 2009;208:1093–8.
Gagnè DJ, Papasavas PK, Maalouf M, et al. Obesity surgery and malignancy: our experience after 1500 cases. Surg Obes Relat Dis. 2009;5:160–4.
Carroll K. Obesity as a risk factor for certain types of cancer. Lipids. 1998;33:1055–9.
Bergstrom A, Pisani P, Tenet V, et al. Overweight as an avoidable cause of cancer in Europe. Int J Cancer. 2001;91:421–30.
Peto J. Cancer epidemiology in the last century and the next decade. Nature. 2001;411:390–5.
Chow W-H, Bolt WJ, Vaughan TL, et al. Body mass index and the risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1998;90:150–5.
Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348:1625–38.
Wolk A, Gridley G, Svensson M, et al. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control. 2001;12:13–21.
Petrelli JM, Calle EE, Rodriguez C, et al. Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of U.S. women. Cancer Causes Control. 2002;13:325–32.
Rodriguez C, Patel AV, Calle EE, et al. Body mass index, height, and prostate cancer mortality in two large cohort of adult men in the United States. Cancer Epidemiol Biomarkers Prev. 2001;10:345–53.
Boru C, Silecchia G, Pecchia A, et al. Prevalence of cancer in Italian obese patients referred for bariatric surgery. Obes Surg. 2005;15:1171–6.
Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13, 715 carcinoid tumors. Cancer. 2003;97:934–59.
Connor SJ, Hanna GB, Frizelle FA. Appendiceal tumors: retrospective clinicopathologic analysis of appendiceal tumors from 7, 970 appendicectomies. Dis Colon Rectum. 1998;41:75–80.
Roggo A, Wood WC, Ottinger LW. Carcinoid tumors of the appendix. Ann Surg. 1993;217:385–90.
Rosso S, Spitale A, Balzi D, et al. Estimate of cancer incidence in Italian regions, 2001. Epidemiol Prev. 2004;28:247–57.
Maggard MA, O’Connell JB, Ko CY. Updated population-based review of carcinoid tumors. Ann Surg. 2004;240:117–22.
Di Betta E, Mittempergher F, Nascimbeni R, et al. Outcome of duodenal switch with a transitory vertical gastroplasty, in super-super-obese patients in an 8-year series. Obes Surg. 2008;18:182–6.
Mittempergher F, Di Betta E, Nascimbeni R, et al. Comparison between a bilio-pacreatic diversion with or without gastroresection after 2 years of follow-up in the treatment of the pathological obesity. Ann Ital Chir. 2008;79:241–5.
Maroun J, Kocha W, Kvols L, et al. Guidelines for the diagnosis and management of carcinoid tumours. Part 1: the gastrointestinal tract. A statement from a Canadian National Carcinoid Expert Group. Curr Oncol. 2006;13:67–76.
Keshishian A, Hamilton J, Hwang L, et al. Carcinoid tumor and bariatric surgery. Obes Surg. 2002;12:874–5.
Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer. 1997;36:560–9.
Mottin CC, Cruz RP, Gomes Thomé G, et al. Carcinoid tumors and morbid obesity. Obes Surg. 2009;19:247–9.
Smith RA, Cokkinides V, Brawley OW. Cancer screening in the United States, 2008: a review of current American Cancer Society guidelines and cancer screening issues. CA Cancer J Clin. 2008;58:161–79.
Goede AC, Caplin ME, Winslet MC. Carcinoid tumors of the appendix. Br J Surg. 2003;90:1317–22.
In't Hof KH, van der Wal HC, Kazemier G, et al. Carcinoid tumor of the appendix: an analysis of 1,485 consecutive emergency appendicectomies. J Gastrointest Surg. 2008;12:1436–8.
Deans GT, Spence RA. Neoplastic lesions of the appendix. Br J Surg. 1995;82:299–306.
Syracuse DC, Perzin KH, Price JB, et al. Carcinoid tumors of the appendix. Mesoappendiceal extension and nodal metastases. Ann Surg. 1979;190:58–63.
Moertel CG, Weiland LH, Nagorney DM. Carcinoid tumor of the appendix: treatment and prognosis. N Engl J Med. 1987;317:1699–701.
Sandor A, Modlin IM. A retrospective analysis of 1570 appendiceal carcinoids. Am J Gastroenterol. 1998;93:422–8.
Hemminki K, Li X. Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologicstudy from Sweden. Cancer. 2001;92:2204–10.
Anderson JR, Wilson BG. Carcinoid tumours of the appendix. Br J Surg. 1985;72:545–6.
CrossRef PubMed Copyright information
© Springer Science + Business Media, LLC 2010